SE7813069L - Peptidderivat och forfarande for framstellning derav - Google Patents

Peptidderivat och forfarande for framstellning derav

Info

Publication number
SE7813069L
SE7813069L SE7813069A SE7813069A SE7813069L SE 7813069 L SE7813069 L SE 7813069L SE 7813069 A SE7813069 A SE 7813069A SE 7813069 A SE7813069 A SE 7813069A SE 7813069 L SE7813069 L SE 7813069L
Authority
SE
Sweden
Prior art keywords
procedures
preparation
peptide derivatives
peptide
derivatives
Prior art date
Application number
SE7813069A
Other languages
English (en)
Swedish (sv)
Inventor
F R Atherton
M J Hall
C H Hassall
R W Lambert
P S Ringrose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7813069L publication Critical patent/SE7813069L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7813069A 1977-12-20 1978-12-19 Peptidderivat och forfarande for framstellning derav SE7813069L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5293877 1977-12-20
GB7842727 1978-11-01

Publications (1)

Publication Number Publication Date
SE7813069L true SE7813069L (sv) 1979-06-21

Family

ID=26267167

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7813069A SE7813069L (sv) 1977-12-20 1978-12-19 Peptidderivat och forfarande for framstellning derav

Country Status (23)

Country Link
EP (1) EP0002534B1 (cs)
JP (1) JPS5492921A (cs)
AT (1) AT366057B (cs)
AU (1) AU4248378A (cs)
BR (1) BR7808342A (cs)
CS (1) CS211394B2 (cs)
CU (1) CU35001A (cs)
DE (2) DE2861537D1 (cs)
DK (1) DK536578A (cs)
ES (1) ES476124A1 (cs)
FI (1) FI783886A7 (cs)
FR (1) FR2450260A1 (cs)
GR (1) GR73085B (cs)
IL (1) IL56208A0 (cs)
IT (1) IT1102401B (cs)
LU (1) LU80671A1 (cs)
MC (1) MC1242A1 (cs)
NL (1) NL7812311A (cs)
NO (1) NO784285L (cs)
NZ (1) NZ189151A (cs)
PT (1) PT68938A (cs)
SE (1) SE7813069L (cs)
ZA (1) ZA786976B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307787C (en) * 1986-06-11 1992-09-22 Melanie J. Loots Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors
CN110156640A (zh) * 2019-06-14 2019-08-23 南京博源医药科技有限公司 一种n-苄氧羰基-氨基酸的制备工艺
CN110143896A (zh) * 2019-06-14 2019-08-20 南京博源医药科技有限公司 一种n-苄氧羰基-l-己氨酸的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1081511B (it) * 1976-07-13 1985-05-21 Hoffmann La Roche Derivati di peptidi e loro preparazione
DE2632188A1 (de) * 1976-07-16 1978-01-26 Hoffmann La Roche Wirkstoffkombinationen
GB1585275A (en) * 1976-07-21 1981-02-25 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids

Also Published As

Publication number Publication date
FI783886A7 (fi) 1979-06-21
LU80671A1 (de) 1980-01-22
DE2861537D1 (en) 1982-02-25
AU4248378A (en) 1979-06-28
GR73085B (cs) 1984-01-31
IT7831023A0 (it) 1978-12-19
ZA786976B (en) 1980-07-30
NO784285L (no) 1979-06-21
CU35001A (en) 1981-12-04
AT366057B (de) 1982-03-10
EP0002534B1 (de) 1982-01-13
NZ189151A (en) 1981-05-15
ATA904178A (de) 1981-07-15
CS211394B2 (en) 1982-02-26
NL7812311A (nl) 1979-06-22
BR7808342A (pt) 1979-08-07
MC1242A1 (fr) 1979-10-26
IL56208A0 (en) 1979-03-12
PT68938A (en) 1979-01-01
FR2450260A1 (fr) 1980-09-26
ES476124A1 (es) 1980-07-16
IT1102401B (it) 1985-10-07
JPS5492921A (en) 1979-07-23
DE2854292A1 (de) 1979-07-05
DK536578A (da) 1979-06-21
EP0002534A1 (de) 1979-06-27

Similar Documents

Publication Publication Date Title
SE7803660L (sv) Cefemderivat och forfarande for deras framstellning
SE7804185L (sv) Cefemderivat och forfarande for deras framstellning
SE7807543L (sv) Polyesteraminoalkylalkoxisilaner och forfarande
SE7802853L (sv) Cefemderivat och forfarande for deras framstellning
SE7807975L (sv) Basiska tioetrar och forfarande for framstellning derav
SE7802786L (sv) Polypeptider och forfarande for framstellning derav
SE7700582L (sv) Peptidderivat och forfarande for dess framstellning
SE7804400L (sv) Cefalosporinforeningar och forfarande for framstellning derav
SE7713903L (sv) Baconanaloger och forfarande for framstellning derav
FI783959A7 (fi) Peptidderivat och deras framstaellning
SE7708121L (sv) Peptidderivat och forfarande for deras framstellning
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
SE7614757L (sv) Somatostatinderivat och forfarande for framstellning derav
SE7802604L (sv) Azoforeningar och forfarande for framstellning derav
SE7708486L (sv) Peptider och forfarande for deras framstellning
SE7706824L (sv) B-laktamantibiotika och forfarande for framstellning derav
SE7808482L (sv) 1,3-difenoxipropan-2-onderivat och forfarande for dess framstellning
SE7800326L (sv) Nya ditienylalkylaminer och forfarande for framstellning derav
SE7708379L (sv) Peptidderivat och forfarande for framstellning derav
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7808066L (sv) Cefalosporiner och forfarande for framstellning derav
SE7804713L (sv) Nytt protein och forfarande for dess framstellning
SE7805184L (sv) Triazolderivat och forfarande for framstellning derav
SE7900346L (sv) Beta- h- endorfinanaloger och forfarande for framstellning derav